Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 36.59% | 22.96% | 56.81% | 11.99% | -6.99% |
| Total Other Revenue | -- | -- | -- | -200.00% | -150.00% |
| Total Revenue | 36.59% | 22.97% | 56.82% | 11.99% | -7.00% |
| Cost of Revenue | 36.45% | 20.74% | 21.83% | -14.01% | -4.51% |
| Gross Profit | 36.68% | 24.52% | 93.13% | 36.42% | -8.64% |
| SG&A Expenses | -10.59% | -6.15% | 3.85% | 12.91% | -1.25% |
| Depreciation & Amortization | 383.87% | 3.28% | 3.28% | 8.62% | 10.71% |
| Other Operating Expenses | 319.77% | 258.40% | -16.29% | -659.78% | 6.61% |
| Total Operating Expenses | 13.22% | 11.59% | 10.34% | -10.99% | -2.23% |
| Operating Income | 100.60% | 58.05% | 112.45% | 127.34% | -30.31% |
| Income Before Tax | 100.10% | 26.72% | 95.92% | 102.87% | -4.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 100.10% | 26.72% | 95.92% | 102.87% | -4.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 100.10% | 26.72% | 95.92% | 102.87% | -4.37% |
| EBIT | 100.60% | 58.05% | 112.45% | 127.34% | -30.31% |
| EBITDA | 107.08% | 59.05% | 113.44% | 129.02% | -30.62% |
| EPS Basic | 90.63% | -581.95% | -237.94% | -476.82% | -428.11% |
| Normalized Basic EPS | 90.80% | -508.25% | -217.25% | -418.10% | -688.30% |
| EPS Diluted | 90.63% | -581.95% | -237.94% | -476.82% | -428.11% |
| Normalized Diluted EPS | 90.80% | -508.25% | -217.25% | -418.10% | -688.30% |
| Average Basic Shares Outstanding | 14.53% | -10.88% | -9.96% | -14.58% | -21.03% |
| Average Diluted Shares Outstanding | 14.53% | -10.88% | -9.96% | -14.58% | -21.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |